Jump to navigation

Home
  • Blog
  • Contact
  • Donate
  • Intranet
  • Newsletter
Stronger health systems. Greater health impact.
  • Home
  • About MSH
    • Our Mission
    • Board & Team
    • Financial Data
      • Supporters
      • Annual Report
    • Careers
  • Our Expertise
    • Strengthening Health Systems
      • Global Health Security
      • Financing Health Services
      • Leadership, Management & Governance
      • Pharmaceutical Management
    • Packages of Care
      • HIV & AIDS
      • Tuberculosis
      • Malaria
      • Women's, Children's, and Adolescents' Health
    • Projects
    • Countries
      • Asia
      • Middle East and North Africa
      • Europe & Eurasia
      • Latin America & Caribbean
      • Sub-Saharan Africa
      • Fragile States
    • Advocacy
      • FCI Program of MSH
      • International Consortium for Emergency Contraception
      • Global Partnerships
    • Learning & Impact
    • MedSource
    • COVID-19: Responding to the Pandemic
  • Resources
    • Tools
    • Publications
    • LeaderNet
  • News & Stories
    • Press Room
      • Stories
      • Events
    • Partnerships

    You are here

    1. Home
    2. Prof. Rabia Kahveci, MD
    Printer Friendly Version

    Prof. Rabia Kahveci, MD

    Senior Technical Advisor, Pharmaceutical Policy and Governance

    Rabia Kahveci is a director of the International Health Technology Assessment Society (HTAi) and the chair of both the HTAi Developing Countries Interest Group and the Eurasian HTA Initiative. Prior to her position with SAFEMed, she was the director of a hospital-based HTA center in Turkey that covered HTA, innovation for medical devices, and real-world evidence. In Turkey, she also served as a member of the Pharmaceuticals Reimbursement Committee of the Turkish Social Security Institution during the transition to universal health coverage and was a co-author of the reimbursement guidelines; the national clinical quality coordinator of the Turkish Ministry of Health, where she coordinating all activities involving HTA, clinical guidelines, quality, and performance-based payment; and the president of the Turkish Evidence-Based Medicine Society.

    Subscribe to Our Newsletter

    Sign Up

    About MSH

    • Our Mission
    • Board & Team
    • Financial Data
    • Careers

    Resources

    • Tools
    • Publications
    • LeaderNet

    News & Stories

    • Press Room
    • Stories
    • Events

    Connect with MSH

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube
    • RSS
    • Donate
    • Partner
    • Careers
    • Privacy and Terms
    • Contact Us
    • Newsletter

    Do Business with MSH

    • Commitment to Ethical Conduct
    • Outside Commercial Suppliers
    Copyright ©2021 Management Sciences for Health. All Rights Reserved.
    Site Design by Digital Loom / Hosted by EchoDitto / Login